In the initial steps of their metabolic pathway, methanotrophic bacteria oxidize methane to methanol with methane monooxygenases (MMOs) and methanol to formaldehyde with methanol dehydrogenases (MDHs). Several lines of evidence suggest that the membrane-bound or particulate MMO (pMMO) and MDH interact to form a metabolic supercomplex. To further investigate the possible existence of such a supercomplex, native MDH from Methylococcus capsulatus (Bath) has been purified and characterized by size exclusion chromatography with multi-angle light scattering and X-ray crystallography. M. capsulatus (Bath) MDH is primarily a dimer in solution, although an oligomeric species with a molecular mass of ∼450−560 kDa forms at higher protein concentrations. The 2.57 Å resolution crystal structure reveals an overall fold and α 2 β 2 dimeric architecture similar to those of other MDH structures. In addition, biolayer interferometry studies demonstrate specific protein−protein interactions between MDH and M. capsulatus (Bath) pMMO as well as between MDH and the truncated recombinant periplasmic domains of M. capsulatus (Bath) pMMO (spmoB). These interactions exhibit K D values of 833 ± 409 nM and 9.0 ± 7.7 μM, respectively. The biochemical data combined with analysis of the crystal lattice interactions observed in the MDH structure suggest a model in which MDH and pMMO associate not as a discrete, stoichiometric complex but as a larger assembly scaffolded by the intracytoplasmic membranes. Figure 1 . Metabolic pathway of M. capsulatus (Bath).
M ethanotrophs are Gram-negative bacteria that utilize methane as their sole carbon and energy source. 1, 2 As central players in the global carbon cycle and potential vehicles for new biological gas-to-liquid (GTL) conversion processes, 3 these organisms have been the focus of intense research efforts. The first step in their metabolic pathway is oxidation of methane by methane monooxygenases (MMOs). 4 The majority of methanotrophs utilize a membrane-bound or particulate MMO (pMMO) 5 that is located within extensive intracytoplasmic membranes. A few methanotroph strains can also express a soluble MMO (sMMO) 6 under conditions of copper starvation. 2, 7 The product of the MMO reaction, methanol, is then converted to formaldehyde by methanol dehydrogenase (MDH) and either further oxidized to carbon dioxide via formaldehyde and formate dehydrogenases or assimilated into multicarbon compounds ( Figure 1 ). 8, 9 Most biochemical studies of methanotroph metabolism have addressed the most difficult step in the pathway, activation of the strong C−H bond in methane by MMOs. For pMMO, which is the predominant MMO in nature, 9 the major focus has been on determining the location and nature of the catalytic site. The pMMO from the well-studied methanotroph Methylococcus capsulatus (Bath) is an ∼300 kDa α 3 β 3 γ 3 trimer, 10,11 comprising three copies each of the pmoB (α), pmoA (β), and pmoC (γ) subunits. The pmoA and pmoC subunits are composed primarily of transmembrane helices, and pmoB consists of two periplasmic cupredoxin-like domains linked by two transmembrane helices. The active site is proposed to be a dinuclear copper center located in the Nterminal pmoB periplasmic domain close to the membrane interface. 12, 13 Another important, but less well studied, aspect of pMMO function is its relationship with the next enzyme in the pathway, MDH, which is located in the periplasm. MDHs are typically ∼145 kDa α 2 β 2 dimers containing a pyrroloquinoline quinone (PQQ)/calcium ion cofactor. 14, 15 This cofactor is located in the α subunit (64 kDa); the exact function of the β subunit (8.5 kDa) remains unclear. 16 Several lines of evidence suggest that pMMO and MDH interact and could form a methane-to-formaldehyde oxidizing supercomplex. First, MDH has been localized not only to the periplasm but also to the intracytoplasmic membranes in M. capsulatus (Bath) 17 as well as in the methanotrophs Methylomonas sp. strain A4 18 and Methylomicrobium album BG8. 19 Second, Dalton and co-workers reported the isolation, purification, and structural characterization of a complex containing both pMMO and MDH. 20, 21 This complex, which exhibited molecular masses of ∼440−687 kDa depending on the technique used, was structurally characterized by cryoelectron microscopy (cryoEM) and single-particle analysis to 16 Å resolution. The resultant structure was interpreted as an α 3 β 3 γ 3 trimer of pMMO capped on the periplasmic side by an α 3 β 3 trimer of MDH. In support of its functional relevance, the propylene epoxidation activity of this complex was moderately higher (2−5-fold) 20, 21 than that of pMMO alone. However, the methane oxidation activity of this complex was not measured; only propylene epoxidation using duroquinol as a reductant and dye-linked oxidation of methanol were reported.
The potential existence of such a supercomplex in vivo is tantalizing because it would afford a direct route for methanol product from the pMMO periplasmic dicopper site to the methanol oxidation site in MDH. Moreover, a supercomplex might also provide insight into the physiological reductant of pMMO. Its electron donor is generally thought to be ubiquinol generated by a type 2 NADH:quinone oxidoreductase 22−24 but was proposed early on to be electrons recycled from the oxidation of methanol by MDH via the MDH electron acceptor, cytochrome c L . 25, 26 A pMMO−MDH complex, with the addition of cytochrome c L , 27 could facilitate electron transfer without the requirement for NADH. 20, 21 Several aspects of the reported supercomplex have remained questionable, however. In all available MDH structures, a dimeric structure is observed, 15,28−33 and no biochemical evidence of the proposed trimeric state is available. In addition, the structure used in the cryoEM model is that of MDH from the methylotroph Methylophilus methylotrophus W3A1. 34, 35 The structure of the cognate M. capsulatus (Bath) MDH has not been determined, hindering further consideration of the structural model. Moreover, the enhancement of pMMO propylene epoxidation activity by the presence of MDH could not be reconstituted by combining purified pMMO and MDH, and formation of a complex between purified pMMO and MDH has not been reported. 11, 20 Thus, it remains unclear whether the interpretation of the observed supercomplex is accurate. To begin addressing these issues, we have isolated and purified native MDH from M. capsulatus (Bath), determined its oligomerization state and crystal structure, and investigated its interactions with M. capsulatus (Bath) pMMO using biolayer interferometry.
■ MATERIALS AND METHODS
Growth of M. capsulatus (Bath). M. capsulatus (Bath) was cultivated as described previously 36 using 12 L of sterile nitrate mineral salts medium supplemented with a solution of trace metals, 50 μM CuSO 4 , and 80 μM FeSO 4 . The pH of the medium was maintained at 6.8, with adjustments made using NaOH and H 2 SO 4 . Growth was initiated by the addition of ∼10 g of frozen cell paste stock resuspended in sterile nitrate mineral salts medium at 45°C. The fermentation was conducted at 45°C with an air:methane gas ratio of 4:1 and an agitation rate of 300 rpm. Cells were harvested once the OD 600 reached 5−7 and centrifuged for 10 min at 8000g. Pelleted cells were washed three times with 25 mM PIPES (pH 7.0), recentrifuged, flash-frozen in liquid nitrogen, and stored at −80°C until they were ready for use.
Purification of MDH from M. capsulatus (Bath). M. capsulatus (Bath) cells (∼20 g) were resuspended in lysis buffer [25 mM PIPES (pH 7.2) and 250 mM NaCl] and sonicated for 10 min (10 s on and 30 s off at 40% amplitude) on ice. The cell debris was removed by centrifugation at 24000g for 1 h, and membranes were separated from the soluble proteins by ultracentrifugation at 160000g for an additional 1 h. The membranes were then washed to isolate pMMO as described previously, 36 Initial protein masses were calculated from a calibration curve of protein standards analyzed on the Superdex 200 column, including ovalbumin (43 kDa), conalbumin (75 kDa), adolase (158 kDa), ferritin (440 kDa), and thyroglobin (669 kDa). The column void volume was determined with blue dextran to be 61 mL (elution time of 67 min). The protein concentration was determined using the Bradford assay with bovine serum albumin (BSA) as a standard. Enzyme activity was measured by the dichlorophenolindophenol (DCPIP) dye-linked dehydrogenase assay using phenazine methosulfate (PMS) as the mediator and methanol as the substrate. 37 The molar absorptivity of DCPIP at 600 nm is 1.91 × 10 7 M −1 cm −1 .
Deriphat-PAGE (D-PAGE) analysis 38, 39 using 25 μg of purified M. capsulatus (Bath) pMMO and MDH was performed on a 4 to 16% Novex Bis-Tris gel (Novagen) using 12.5 mM Tris and 100 mM glycine (pH 8.3). The cathode buffer contained 0.2% (w/v) disodium n-lauryl-β-iminodipropionate (Deriphat) detergent. Gels were run at 100 V and 4°C to improve the resolution and stained with Coomassie dye. In-gel activity assays were performed as described previously. 40, 41 Briefly, the gel was incubated in a solution containing 50 mM Tris (pH 8.0), 15 mM NH 4 Cl, 0.5 mM PMS, 1 mM nitroblue tetrazolium chloride (NBT), and 20 mM MeOH. Activity is detected by the reduction of NBT, which becomes blue in color. Once blue bands appeared, the reaction was stopped by the addition of water and the gel was compared with the Coomassie-stained gel. Isolation, Solubilization, and Purification of pMMO from M. capsulatus (Bath). pMMO was purified as described previously with some modifications. 20 The membranes were isolated as described above, homogenized three times using a Dounce homogenizer, and resuspended in lysis buffer at a final concentration of 10−20 mg/mL, after which 1 mL aliquots were flash-frozen in liquid N 2 and stored at −80°C. Frozen membranes were thawed on ice and washed three times with 25 mM PIPES (pH 7.2), 0.5 M NaCl, 1 mM benzamidine, and 40 μM CuSO 4 . Washed membranes were then solubilized with the detergent n-dodecyl β-D-maltoside (DDM) (Anatrace) by the addition of 1.5 mg of DDM/mg of protein at 4°C for at least 1 h while being gently stirred. The sample was concentrated to 20 mg/mL using a Centriprep MWCO 50 device and loaded onto a Superdex 200 16/600 column (GE Healthcare) preequilibrated with 25 mM PIPES (pH 7.2), 150 mM NaCl, 0.03% DDM, and 1 mM benzamidine. Sample purity was assessed by sodium dodecyl sulfate−polyacrylamide gel electrophoresis (SDS−PAGE), and pure fractions were collected and concentrated with a Centriprep MWCO 50 device to 10−20 mg/mL. Samples were flash-frozen and stored at −80°C. The protein concentration was determined by the Detergent-Compatible Lowry Assay (Bio-Rad) using BSA as a standard. The recombinant spmoB protein, which corresponds to the soluble domains of the pMMO pmoB subunit, was prepared as described previously. 12, 42 Size Exclusion Chromatography with Multi-angle Light Scattering (SEC-MALS). The molecular mass of MDH at various protein concentrations was determined by conducting SEC-MALS experiments. Analyses were performed using an Agilent Technologies 1100 LC high-performance liquid chromatography system (Agilent Technologies, Santa Clara, CA) equipped with a Dawn Heleos II 18-angle MALS light scattering detector, an Optilab T-rEX (refractometer with extended range) refractive index detector, a WyattQELS quasielastic (dynamic) light scattering (QELS) detector, and ASTRA software for data analysis (all from Wyatt Technology, Santa Barbara, CA). Varying concentrations of MDH in 25 mM PIPES (pH 7.25), 1 mM benzamidine, and 0.03% DDM (100 μL sample size) were injected onto a pre-equilibrated Superdex 200 10/300 GL column (GE Healthcare) at a flow rate of 0.5 mL/min at room temperature. The ASTRA software was used to calculate the molecular mass of the α 2 β 2 dimer and higherorder oligomers. This software also determines the polydispersity of the protein sample across the elution peaks. The buffer differential index of refraction, dn/dc, was determined to be 0.18 mL/g, and BSA was used as a control protein. The relative percentages of the dimer and multimer were determined from the UV−vis elution profiles using Chemstation software (Agilent).
Biolayer Interferometry. The affinity of purified MDH for purified pMMO, both from M. capsulatus (Bath), was determined using a ForteBio BLItz biolayer interferometer in the Northwestern Keck Biophysics Facility. Amine reactive second-generation (AR2G) biosensors (ForteBio) were hydrated in 15 mM NaOAc (pH 5.5) for 10 min prior to each experimental run. A single run is divided into six steps: (i) buffer baseline, in which the amine reactive sensor is immersed in 15 mM NaOAc (pH 5.5) for 60 s to establish a zero baseline; (ii) sensor activation, in which biosensors are activated for 5 min with a mixture of 20 mg/mL EDC {1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide hydrochloride} and 5 mg/mL sulfo-NHS (N-hydroxysulfosuccinimide) in water;
(iii) ligand loading, in which MDH diluted to 1 mg/mL with 15 mM NaOAc (pH 5.5) is reacted with the biosensor for 5 min and then deactivated for 5 min with 1 M ethanolamine (pH 8.5); (iv) baseline, in which the biosensor is immersed in either pMMO buffer [25 mM PIPES (pH 7.2), 1 mM benzamidine, and 0.03% DDM] or spmoB buffer [50 mM Tris (pH 8.0) and 150 mM NaCl] for 2 min to remove any unbound MDH; (v) association, in which the amine-reacted MDH biosensor tip is immersed in purified pMMO or refolded spmoB for 5 min; and (vi) dissociation, in which the MDH− protein complex formed during association is transferred to the corresponding buffer for 5 min to dissociate. Runs were performed with pMMO concentrations of 0.5−5 μM. Sample runs with spmoB were performed at protein concentrations of 0.3−30 μM. Immobilized BSA was used as a negative control at a concentration of 0.3 mg/mL with 30 μM spmoB. A new biosensor tip was used for each run. The sensorgrams were corrected against a buffer only reference and fit with the ForteBio Data Analysis package assuming a 1:1 Langmuir binding model with the global fitting function.
Determination of the Structure of MDH from M. capsulatus (Bath). For crystallization, MDH was exchanged into 25 mM HEPES (pH 7.5), 150 mM NaCl, and 10% glycerol and concentrated to 20 mg/mL. Crystals were obtained by the hanging drop diffusion method at 4°C by mixing 2 μL of protein with 1 μL of a reservoir solution containing 0.1 M NaHEPES (pH 7.5) and 30% PEG 4000. Rhombic crystals formed overnight. The crystals were cryoprotected in a reservoir solution containing 40% 2methyl-2,4-pentanediol (MPD) and flash-frozen in liquid N 2 . Data were collected at sector 21 (Life Sciences Collaborative Access Team, LS-CAT) of the Advanced Photon Source at Argonne National Laboratory. Initial data processing and integration were conducted using HKL2000, 43 with the resolution limits determined by inspection. After the initial model was built, the data were reprocessed using the xia2 44 pipeline to XDS 45 and scaled with AIMLESS. 46 This reprocessing was conducted to ensure that the high R merge values from HKL2000 are not due to an inappropriate resolution limit. The resolution is determined automatically by xia2, and both programs gave a resolution cutoff of 2.57 Å. The data collection statistics are summarized in Table 1 .
The structure of MDH was determined by molecular replacement with Phaser 47 from the CCP4 program suite, 48 using the coordinates of Me. methylotrophus W3A1 MDH (Protein Data Bank entry 2AD7) as a starting model. 49 Initial refinement was conducted with Refmac, 50 followed by several rounds of refinement with phenix.refine, 51 which fixes rotamer geometry and water coordination and manually flips His/Asn/ Gln residues. COOT was used for manual building of the structure and structural alignments. 52 Coordinates for the ligand pyrroloquinoline quinone (PQQ) were obtained from the Me. methylotrophus W3A1 MDH structure, and the library of restraints was generated using the eLBOW 51 been reported previously. 55, 56 For this study, MDH was isolated from the M. capsulatus (Bath) soluble supernatant during membrane isolation. MDH is present at high levels in the soluble fraction and could be monitored during purification by following the PQQ cofactor absorbance at 345 nm. After four column chromatography steps, a >90% pure sample of MDH was obtained ( Figure S1 of the Supporting Information) with a typical yield of ∼30 mg/L. The purified MDH exhibits a specific activity of 183 ± 32 nmol min −1 mg −1 as measured by the dye-linked DCPIP assay, in close agreement with previously reported values for M. capsulatus (Bath) MDH. 55, 56 Solution Oligomerization State of M. capsulatus (Bath) MDH. Initial size exclusion chromatography (SEC) analysis shows a single peak with a molecular mass of ∼144 kDa, corresponding to the α 2 β 2 dimer. After the sample is concentrated, stored at −80°C, and then thawed, a second peak attributable to a higher-order oligomer appears ( Figure S2 of the Supporting Information). These results are consistent with the previous observation of two distinct oligomeric species by single-particle analysis of electron micrographs. 55 The MDH oligomerization state was further investigated by SEC coupled to an in-line multi-angle light scattering detector (SEC-MALS). This technique determines the molecular mass of a protein independent of its SEC elution profile. 57 Four MDH samples with concentrations of up to 20 mg/mL were analyzed by SEC-MALS. All samples eluted as two peaks, the first (19.5 mL) corresponding to a molecular mass of ∼460−560 kDa and the second (26 mL) to a molecular mass of 144 kDa, which is the α 2 β 2 dimer (Figure 2A) . The higher-mass species is much less homogeneous than the dimer as indicated by the distribution of masses detected by light scattering (Figure 2A ). Its mass suggests the presence of three or four α 2 β 2 dimers, assuming a mass of ∼72.5 kDa (http://expasy.org) for the αβ monomer.
The fraction of MDH present as the oligomer increases with increasing protein concentrations (Figure 2 ). At 1 mg/mL, the protein exists as ∼90% dimer and 10% oligomer, whereas at 20 mg/mL, the percentages shift to 70% dimer and 30% oligomer ( Figure 2B ). Because of saturation of the MALS detector, concentrations of >20 mg/mL could not be analyzed by this technique, but analysis of MDH concentrated to >100 mg/mL using the same column matrix coupled to a UV−vis detector ( Figure S3 of the Supporting Information) indicates the presence of 10% dimer and 90% oligomer. Reanalysis of either the dimer or oligomer fraction on the same column indicates the presence of both species. Thus, the dimer and the oligomer are in equilibrium, and the oligomer begins to associate more readily at high concentrations ( Figure S3 of the Supporting Information). The dimer and higher-order oligomers are also evident on native D-PAGE gels stained with Coomassie and treated with PMS and NBT to detect MDH activity (Figure 3 ). Both the dimer and the oligomer exhibit MDH activity, whereas no activity is detected for pMMO, which was used as a control. The major species observed by D-PAGE is the dimer, consistent with the low protein concentration used for the gel. This result indicates that the oligomeric MDH species observed by SEC and SEC-MALS represent an active form of MDH.
Interaction between MDH and pMMO from M. capsulatus (Bath). The possibility of a specific protein− protein interaction between MDH and pMMO was investigated by biolayer interferometry. MDH was immobilized on an amine chip using standard NHS/EDC coupling at 1 mg/mL, and interactions with pMMO (0.5−5 μM) were assayed. A concentration-dependent interaction between immobilized MDH and pMMO was observed ( Figure 4A ). Analysis of the sensorgram data yielded a K D value of 833 ± 409 nM. To assess whether the interaction could be related to the proposed complex between MDH and the periplasmic domains of pMMO, we also conducted experiments with spmoB (0.3−30 μM). A weaker interaction was observed, yielding a K D value of 9.0 ± 7.7 μM ( Figure 4B) . Control experiments performed with BSA showed no interaction ( Figure 4C ). Attempts to isolate a MDH−pMMO complex by SEC were not successful, however.
Overall Structure of M. capsulatus (Bath) MDH. The M. capsulatus (Bath) MDH X-ray structure was determined to 2.57 Å resolution. MDH crystallizes with four α 2 β 2 protomers in the asymmetric unit (chains A/J and E/M, chains B/I and G/O, chains C/K and D/L, and chains F/N and H/P). The average rmsd between protomers is 0.189 Å, using chain A (α subunit) and chain J (β subunit) as the reference protomer. Because of the presence of periplasmic signal sequences, the model for the α subunit begins at Asn 29, and the model for the β subunit begins at Tyr 23. There are no gaps within the chains. The β subunit in protomers I−L is modeled through Ile 93, whereas the C-terminal residue, Lys 94, is also modeled in protomers M−P.
The overall fold is the same as those of other MDH structures, with eight antiparallel four-stranded β sheets forming a propeller. 15 Each four-stranded β sheet blade in the propeller has the typical "W" motif, and the blades are labeled W1−W8 according to nomenclature from previous structures ( Figure 5A ). 28 There are several flanking α helices as well as an additional β hairpin and a three-stranded sheet insertion between propeller blades W5 and W6 ( Figure 5A ). The PQQ cofactor and Ca 2+ ion are located in the center of the propeller as in other MDH structures. The PQQ is sandwiched between Trp 271 and a disulfide bond formed by residues Cys 131 and Cys 132 common to other methanol dehydrogenase enzymes. 14, 15 An extensive hydrogen bonding network stabilizes the PQQ. The Ca 2+ ion is coordinated by the PQQ C-7 carboxylate, C-5 carbonyl, and N-6 quinoline nitrogen moieties as well as residues Glu 205, Asn 289, and Asp 331 ( Figure 5B) . The β subunit is mainly α helical in structure and extends the length of the α subunit between β sheets W2 and W3 of the propeller motif ( Figure 5A ). The N-terminus of the β subunit contains a flexible loop region from residue Tyr 23 to Asp 55 before the long α helix begins at residue Pro 56. Each β subunit interacts extensively with its associated α subunit. These interactions include three salt bridges. Residue Lys 38 from the β subunit interacts with Glu 295 and Glu 329 from the α subunit; residue Glu 70 from the β subunit interacts with Arg 225 from the α subunit, and residues Arg 72 and Arg 76 from the β subunit interact with Glu 176 from the α subunit.
Secondary structure matching with COOT between the structures of the αβ protomers of M. capsulatus (Bath) MDH (644 residues) and Me. methylotrophus W3A1 MDH (640 residues) 49 results in a sequence identity of 65%. This superposition of 631 residues yields an rmsd of 0.69 Å and reveals several minor gaps and insertions in loop regions as well as some substitutions at the PQQ binding site. Residues Met 102 and Ser 162 in Me. methylotrophus W3A1 MDH both hydrogen bond to PQQ and are replaced with alanines in the M. capsulatus (Bath) MDH structure. In addition, Cys 144 and Cys 167 (Me. methylotrophus W3A1 numbering) are both serine residues in M. capsulatus (Bath) MDH, resulting in one fewer intrachain disulfide bond, though this substitution is common in other MDHs.
Oligomerization State of M. capsulatus (Bath) MDH in the Crystal Structure. The dimer detected by SEC-MALS is observed in the structure and corresponds to the previously observed α 2 β 2 dimer ( Figure 5C ). The surface area of the dimer interface is ∼1400 Å 2 . The dimer is saddle-shaped with the two β subunits, which are not involved in dimerization, located in the stirrups position of the saddle. In the dimer, the two α subunits interact via β strands from propeller blades W7 and W8, forming an extended β sheet network. There are additional interactions between the C-terminal loop regions of each chain and the loop region after propeller blade W1. The interface includes approximately 30 hydrogen bonds. Among key interacting residues are Arg 112 and Gln 532, which correspond to Gly 84 and Lys 502, respectively, in Me. methylotrophus W3A1 MDH. 49 Further comparison of the interfaces reveals 22 hydrogen bonds at the Me. methylotrophus W3A1 MDH dimer interface as compared to 30 in M. capsulatus (Bath) MDH.
Within the crystal lattice, the dimers pack together in alternating pairs with all the lattice contacts involving the α subunits. The net result is a bilayer-like structure with the β subunits on opposite sides pointing toward the solvent channels ( Figure 6 ). Interface analysis with PDBePISA 54 indicates that no higher-order stable oligomers are present. Thus, the ∼460−560 kDa species detected by SEC-MALS is likely not represented by the arrangement of molecules in the crystal structure. This is not surprising because the α 2 β 2 dimer fraction was isolated by SEC ( Figure S2 of the Supporting Information), and the dimer is predominant at the concentration of 20 mg/mL used for crystallization.
■ DISCUSSION
These data indicate that M. capsulatus (Bath) MDH is primarily an α 2 β 2 dimer in solution but can form ∼460−560 kDa oligomers at high concentrations, which also exhibit MDH activity (Figure 3) . The oligomeric species is heterogeneous, and there is no evidence of the existence in solution of an α 3 β 3 trimer, as proposed for the complex characterized by cryoEM. 21 In addition, an interaction between MDH and pMMO has been detected by biolayer interferometry. This interaction appears to be specific as demonstrated by control experiments with spmoB and BSA. Finally, the M. capsulatus (Bath) MDH crystal structure reveals a dimer that is similar to other MDH structures. No unusual higher-order oligomers are present in the structure.
Taken together, these findings have several important implications for the proposed pMMO−MDH supercomplex. First, the biolayer interferometry data provide evidence of direct interactions between the two isolated enzymes. Because the α and β subunits of MDH contain a large number of exposed lysine residues, the immobilization is nonspecific, preventing identification of the MDH regions involved in interaction with pMMO. The fact that an interaction is also detected with spmoB, which includes only the periplasmic domains of pMMO, is consistent with MDH's location in the periplasm as well as with numerous studies indicating that MDH can be associated with the membranes. 17−19 It is not surprising that the interaction of MDH with pMMO is an order of magnitude stronger than that with spmoB because spmoB alone does not form trimers and has limited solubility. 12 Despite the biolayer interferometry data, we were not able to isolate a stable pMMO−MDH complex by SEC, consistent with previous studies in which the complex and its activity could not be reconstituted by combining purified proteins. 11, 20 Thus, the association may be dynamic and likely depends on the presence of the membrane or additional protein components. Affixing MDH to the biosensor surface may partially mimic such requirements.
The observed oligomerization states of MDH in solution and in the crystal also suggest that interactions both among MDH dimers and between MDH and pMMO are transient and/or facilitated by additional components. The cryoEM model was suggested to represent an α 3 β 3 trimer of MDH capping the periplasmic regions of the pMMO trimer. 21 One α 2 β 2 dimer was fit into two lobes of density, but it was not clear whether an αβ protomer from a second dimer could fit the third lobe or whether a new trimeric α 3 β 3 structure would be required. The SEC-MALS data indicate that ∼460−560 kDa M. capsulatus (Bath) MDH oligomers can form at high concentrations; such a mass would be consistent with three or four α 2 β 2 dimers or two or three α 3 β 3 trimers. However, the M. capsulatus (Bath) MDH structure reveals an α 2 β 2 dimer similar to other MDH structures with no evidence of a stable higher-order oligomerization state. Given the absence of a stable assembly in the ∼460−560 kDa range in the structure and the heterogeneity detected by SEC-MALS, it seems unlikely that a discrete higher-order oligomerization state interacts with pMMO. Instead, a more transient association of MDH dimers may occur in the presence of membrane-embedded pMMO.
The crystal packing arrangement provides some insight into how multiple MDH dimers might assemble in vivo. In the crystal, the dimers are arranged in pairs. The ∼460−560 kDa species observed by SEC-MALS may represent a partial assembly of MDH dimers into weakly associated pairs. Within the crystal lattice, all the β subunits are exposed to the solvent ( Figure 6 ). The β subunit is lysine-rich (11 of 72 residues), with five lysines at the N-terminus and the remainder protruding from the C-terminal α helix. The exact function of the β subunit and these lysine residues is not known. One possibility suggested previously for methylotrophs is docking with cytochrome c L via electrostatic interactions, 58 although cross-linking data point to interactions with the α subunit. 59, 60 Alternatively, the positively charged lysine residues might interact with pMMO or with negatively charged phospholipid headgroups at the periplasmic membrane surface, analogous to the lysine-mediated binding of the yeast copper chaperone for superoxide dismutase (CCS) to lipid bilayers. In that system, interaction with the membrane allows CCS to find its source of copper, the transporter Ctr1. 61 Importantly, the intracytoplasmic membranes in methanotrophs typically form stacked or bundled structures. 1, 2, 18, 19 It is possible to envision a "bilayer" of MDH as observed in the crystal lattice ( Figure 6 ) interacting with multiple sections of the pMMO-containing membranes. The formation of intracytoplasmic membranes accompanies pMMO expression, 62, 63 and beyond housing pMMO, these membranes likely play a role in assembling other membrane-bound and periplasmic proteins, including respiratory complexes. Further study of the interplay among pMMO, MDH, intracytoplasmic membranes, and other metabolic enzymes is an important direction for future work. 
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